Answers are grounded in this paper and cite their sources.
Meta-analysis evaluates clinical potential of IDH inhibitors in lower-grade gliomas, suggesting new therapeutic strategies.
This meta-analysis evaluates the clinical potential of mutant isocitrate dehydrogenase (IDH) enzyme inhibitors—ivosidenib and vorasidenib—as an intervention strategy aimed at disrupting glioma pathogenesis
No takes yet. Share an insight, caveat, or question.
Afzal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: